China's Sinopharm says coronavirus vaccine could be ready by year-end


FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/

BEIJING: A coronavirus vaccine candidate developed by China National Pharmaceutical Group (Sinopharm) could be ready for public use by the end of this year, state media reported on Wednesday, ahead of a previous expectation it may become available in 2021.

Sinopharm Chairman Liu Jingzhen told state broadcaster CCTV the company expects to finish late-stage human testing within about three months.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Malaysia's private non-financial sector's credit growth moderated to 4.8% in September
US tariffs on China to have mixed impact on Asean economies - OCBC
Minox International proposes 1-for-2 bonus issue of warrants
UBS posts bigger-than-expected net profit in third quarter
China and Hong Kong stocks drop as US election risks loom
StanChart third-quarter profit more than doubles on strong wealth growth, raises guidance
Bursa Malaysia's net profit jumps 42% to RM85.74mil in 3Q as ADV climbs
FBM KLCI slides as US election jitters mount
Australian dollar stuck near three-month lows on mixed inflation data
Axis-REIT raises RM449.73mil from private placement

Others Also Read